Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 1
1 (25.0%)Effects of a NeuroAD System, for the Treatment of Alzheimer Disease
Not Applicable
Terminated
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Neuronix Ltd
- Target Recruit Count
- 1
- Registration Number
- NCT02166827
- Locations
- 🇮🇱
Shaare Zedek, Jerusalem, Israel
Effect of NeuroAD on Alzheimer Patients
Not Applicable
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Neuronix Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT01825317
- Locations
- 🇰🇷
Chungnam national university hospital, Daejeon Geriatric Medical Center, Daejeon, Korea, Republic of
Effect of NeuroAD on the Cognitive Function of Alzheimer Patients
Not Applicable
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Neuronix Ltd
- Target Recruit Count
- 131
- Registration Number
- NCT01825330
- Locations
- 🇺🇸
Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸ATP Clinical Research, Inc., Costa Mesa, California, United States
🇺🇸Miami Jewish Health Systems, Miami, Florida, United States
TMS Stimulation and Cognitive Training in Alzheimer Patients
Phase 1
Completed
- Conditions
- Alzheimer DiseaseMild to Moderate
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2013-03-28
- Lead Sponsor
- Neuronix Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT01168245
- Locations
- 🇮🇱
Assaf-Harofeh Medical Center, Beer Yaakov, Israel
News
No news found